A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.
Personalized organoids — ‘mini-organs’ — may accelerate treatment for patients with rare genetic disorders. Courtesy of Europeana via Unsplash Across the globe, countless babies ...
10, 2025 /PRNewswire/ -- Ouro Medicines, a biotechnology ... opportunity to define the future of treatment for people with immune-mediated diseases because the standard of care today leaves ...